Cargando…

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders

OBJECTIVE: To compare long GnRH agonist with GnRH antagonist protocol in poor responders. MATERIALS AND METHODS: Medical charts of 531 poor responder women undergoing in-vitro fertilization (IVF) cycle at Zeynep Kamil Maternity and Children’s Hospital, IVF Center were retrospectively analysed. Those...

Descripción completa

Detalles Bibliográficos
Autores principales: Şahin, Sadık, Selçuk, Selçuk, Devranoğlu, Belgin, Kutlu, Tayfun, Kuyucu, Melda, Eroğlu, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558361/
https://www.ncbi.nlm.nih.gov/pubmed/28913020
http://dx.doi.org/10.4274/tjod.80090
Descripción
Sumario:OBJECTIVE: To compare long GnRH agonist with GnRH antagonist protocol in poor responders. MATERIALS AND METHODS: Medical charts of 531 poor responder women undergoing in-vitro fertilization (IVF) cycle at Zeynep Kamil Maternity and Children’s Hospital, IVF Center were retrospectively analysed. Those who received at least 300 IU/daily gonadotropin and had ≤3 oocytes retrieved were enrolled in the study. Poor responders were categorized into two groups as those who received long GnRH agonist or GnRH antagonist regimen. RESULTS: Treatment duration and total gonadotropin dosage were significantly higher in women undergoing the long GnRH agonist regimen compared with the GnRH antagonist regimen (p<0.001 for both). Although the number of total and mature oocytes retrieved was similar between the groups, good quality embryos were found to be higher in the GnRH antagonist regimen. The day of embryo transfer and number of transferred embryos were similar in the groups. No statistically significant differences were detected in pregnancy (10.5% vs 14.1%), clinical pregnancy (7.7% vs 10.6%) and early pregnancy loss rates (27.2% vs 35%) between the groups. CONCLUSION: GnRH antagonist regimen may be preferable to long GnRH regimen as it could decrease the cost and treatment duration in poor responders.